Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
18/05/2026 08:07
May 18 (Reuters) - Piramal Pharma Ltd PIRM.NS: PIRAMAL PHARMA LTD - ANNOUNCES SUCCESSFUL CLOSURE OF US FDA INSPECTION AT DIGWAL FACILITY PIRAMAL PHARMA LTD - US FDA ISSUES ESTABLISHMENT INSPECTION REPORT Source text: ID:nBSEnYRM5 Further company coverage: PIRM.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington